Peter St George-Hyslop is a medical scientist, neurologist and molecular geneticist who is distinguished for his research into neurodegenerative disorders, including Alzheimer’s disease (AD). In particular, he discovered several genes that when mutated lead to early onset hereditary AD, accelerating our understanding the disease and the development of potential treatments.
His discovery that defective genes encoding presenilins are a cause of familial AD led to presenilins becoming a new target for treatments. He went on to show that mutated presenilins contribute to the generation of the amyloid beta protein — deposition of which is the earliest sign of AD in those carrying such genes. His work on several other neurodegeneration-related genes and proteins (including SORLA, TREM2, FUS) has led to an understanding of the role of vesicular transport, inflammation and perturbed RNA granule biology.
Peter has led an AD research programme as Professor of Experimental Neuroscience at the University of Cambridge since 2007. He was awarded the Howard Hughes Medical Institute International Scholar Award in both 1997 and 2002, and has received several other notable awards.
Professor of Experimental Neuroscience, Cambridge Institute for Medical Research, Addenbrooke's Hospital
Director, Tanz Centre for Research In Neurodegenerative Diseases, University of Toronto
Interest and expertise
- Health and human sciences
- Biochemistry and molecular cell biology
- Biophysics and structural biology, Cell biology (incl molecular cell biology)
Alzheimer disease, frontotemporal dementia, Motor neuron diseases, Amyotrophic lateral sclerosis, Amyloidosis, Protein aggregation, neuroinflammation, Glial cells, Neurodegenerative diseases, rna granules, Ribonucleoproteins, big data